C.difficile
Showing 1 - 25 of 1,773
Clostridoides Difficile Associated Disease Trial in United States (C. difficile vaccine (previously studied formulation), C.
Recruiting
- Clostridoides Difficile Associated Disease
- C. difficile vaccine (previously studied formulation)
- +4 more
-
Anaheim, California
- +8 more
Apr 6, 2023
Clostridioides Difficile Infection Trial (LMN-201, Placebo)
Not yet recruiting
- Clostridioides Difficile Infection
- LMN-201
- Placebo
- (no location specified)
Nov 15, 2022
Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea Trial in Charlottesville
Recruiting
- Clostridioides Difficile Infection
- +3 more
-
Charlottesville, VirginiaUVA Health Systems
Nov 2, 2022
C. Difficile Infection, Cancer Trial in New York (Fecal Microbiota Transplantation (FMT))
Active, not recruiting
- C. Difficile Infection
- Cancer
- Fecal Microbiota Transplantation (FMT)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 26, 2022
IBD, Clostridium Difficile Infections, Microtia Trial in Shanghai (Clostridioides difficile toxin detection)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Clostridioides difficile toxin detection
-
Shanghai, Shanghai, ChinaShanghai jiaotong university, school of medicine, affliated Renj
Feb 3, 2023
Clostridium Difficile Trial in Bronx (Bezlotoxumab)
Terminated
- Clostridium Difficile
-
Bronx, New YorkMontefiore Medical Center
Oct 13, 2022
C. Difficile Trial (Arm 1: Routine care, Arm 2: Preemptive C. difficile infection prevention bundle)
Recruiting
- C. Difficile
- Arm 1: Routine care
- Arm 2: Preemptive C. difficile infection prevention bundle
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 23, 2022
Immune Response to C.Difficile Infection
Recruiting
- Clostridium Difficile
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 31, 2022
Clostridium Difficile Infections, Stem Cell Transplant Complications Trial (Vancomycin, Placebo)
Not yet recruiting
- Clostridium Difficile Infections
- Stem Cell Transplant Complications
- Vancomycin
- Placebo
- (no location specified)
Feb 17, 2022
Diarrhea Trial in New York (Ursodiol)
Completed
- Diarrhea
-
New York, New YorkNew York University Langone Medical Center
Dec 21, 2021
Clostridium Difficile Infection Trial in Minneapolis (Fecal Microbiota Therapy (FMT), Placebo)
Recruiting
- Clostridium Difficile Infection
- Fecal Microbiota Therapy (FMT)
- Placebo
-
Minneapolis, MinnesotaMinneapolis VA Health Care System, Minneapolis, MN
Mar 3, 2022
Clostridium Difficile Infection Trial in Victoria (Fidaxomicin)
Terminated
- Clostridium Difficile Infection
-
Victoria, BC - British Columbia, CanadaChristine Lee
Feb 23, 2022
C. Difficile Enteritis, Gut Microbiota Dysbiosis Trial in Zurich, Winterthur, Bern (Nagasin, maltodextrin)
Recruiting
- C. Difficile Enteritis
- Gut Microbiota Dysbiosis
- Nagasin
- maltodextrin
-
Zurich, ZH, Switzerland
- +2 more
Mar 23, 2023
Clostridium Difficile, Inflammatory Bowel Disease, Crohn's Disease Trial in Philadelphia (Fecal Microbiota Transplant)
Active, not recruiting
- Clostridium Difficile
- +3 more
- Fecal Microbiota Transplant
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Apr 4, 2022
Active C. Difficile Colitis Trial in Houston (Microbiota Transplantation (FMT))
Enrolling by invitation
- Active C. Difficile Colitis
- Microbiota Transplantation (FMT)
-
Houston, TexasMichael E DeBakey Veterans Affairs Medical Center
Feb 24, 2022
Clostridium Difficile Trial in Calgary (Near Patient Testing, SOP for C. difficile diagnostics)
Completed
- Clostridium Difficile
- Near Patient Testing
- SOP for C. difficile diagnostics
-
Calgary, Alberta, Canada
- +1 more
Sep 27, 2021
Clostridium Difficile Trial in Columbus (Fecal Microbiota Transplantation)
Recruiting
- Clostridium Difficile
- Fecal Microbiota Transplantation
-
Columbus, OhioGI Division, Nationwide Children's Hospital
Mar 9, 2022
Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile
Completed
- Clostridium Infections
- C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
- +2 more
-
Gent, BelgiumGSK Investigational Site
Jun 9, 2022
FQ Restriction for the Prevention of CDI
Enrolling by invitation
- Clostridium Difficile
- +2 more
- fluoroquinolone preprescription authorization
- Control
-
Phoenix, Arizona
- +7 more
Mar 2, 2022
Clostridium Difficile Infection, Ulcerative Colitis, Indeterminate Colitis Trial in Stony Brook (Fecal Microbial
Completed
- Clostridium Difficile Infection
- +2 more
- Fecal Microbial Transplantation
-
Stony Brook, New YorkStony Brook University Hospital
Feb 21, 2022
Clostridium Difficile Trial in Miami, Chicago (Serum-derived bovine immunoglobulin/protein isolate (SBI), Placebo)
Terminated
- Clostridium Difficile
- Serum-derived bovine immunoglobulin/protein isolate (SBI)
- Placebo
-
Miami, Florida
- +2 more
Nov 10, 2021
Clostridioides Difficile Infection Trial in Madrid (Oral Vancomycin, Placebo)
Recruiting
- Clostridioides Difficile Infection
- Oral Vancomycin
- Placebo
-
Madrid, SpainUnidad de Enfermedades Infecciosas. Hospital Universitario 12 de
Aug 2, 2022
Clostridium Difficile Infection Trial in Milwaukee (Vancomycin Oral Capsule, Placebo Oral Capsule)
Completed
- Clostridium Difficile Infection
- Vancomycin Oral Capsule
- Placebo Oral Capsule
-
Milwaukee, WisconsinMedical College of Wisconsin, Inc.
Oct 12, 2021
COMBACTE-CDI Understanding the Burden of C. Difficile Infection
Completed
- Clostridium Difficile Infection
- No intervention
-
Leeds, West Yorkshire, United KingdomUniversity of Leeds
Jan 10, 2022